MAY SIMON 4

Accession 0001062993-23-017638

CIK 0000012208other

View on SEC.gov Company Profile

Filed

Sep 5, 8:00 PM ET

Accepted

Sep 6, 12:55 PM ET

Size

31.0 KB

Accession

0001062993-23-017638

Insider Transaction Report

Form 4

Period: 2023-09-01

BIO-RAD LABORATORIES, INC.BIO BIOB

MAY SIMON

EVP, President, LSG

Transactions

Tax Payment
Bio-Rad A Common Stock
2023-09-02$394.60/sh−142$56,033→ 2,455.989 total
Exercise/Conversion
Bio-Rad A Common Stock
2023-09-04+600→ 3,399.989 total
Award
Restricted Stock Units
2023-09-01+3,005→ 3,005 total
Exercise: $0.00→ Bio-Rad A Common Stock (3,005 underlying)
Exercise/Conversion
Restricted Stock Units
2023-09-01−520→ 1,562 total
Exercise: $0.00→ Bio-Rad A Common Stock (520 underlying)
Exercise/Conversion
Restricted Stock Units
2023-09-01−371→ 744 total
Exercise: $0.00→ Bio-Rad A Common Stock (371 underlying)
Exercise/Conversion
Restricted Stock Units
2023-09-03−526→ 526 total
Exercise: $0.00→ Bio-Rad A Common Stock (526 underlying)
Tax Payment
Bio-Rad A Common Stock
2023-09-01$394.60/sh−180$71,028→ 1,946.989 total
Exercise/Conversion
Bio-Rad A Common Stock
2023-09-01+520→ 2,126.989 total
Tax Payment
Bio-Rad A Common Stock
2023-09-01$394.60/sh−129$50,903→ 2,188.989 total
Exercise/Conversion
Bio-Rad A Common Stock
2023-09-02+409→ 2,597.989 total
Tax Payment
Bio-Rad A Common Stock
2023-09-04$394.60/sh−295$116,407→ 3,104.989 total
Exercise/Conversion
Restricted Stock Units
2023-09-02−409→ 410 total
Exercise: $0.00→ Bio-Rad A Common Stock (409 underlying)
Exercise/Conversion
Restricted Stock Units
2023-09-04−600→ 0 total
Exercise: $0.00→ Bio-Rad A Common Stock (600 underlying)
Exercise/Conversion
Bio-Rad A Common Stock
2023-09-01+371→ 2,317.989 total
Exercise/Conversion
Bio-Rad A Common Stock
2023-09-03+526→ 2,981.989 total
Tax Payment
Bio-Rad A Common Stock
2023-09-03$394.60/sh−182$71,817→ 2,799.989 total

Footnotes (9)

[F1]Shares of Class A common stock acquired on the vesting of restricted stock units.
[F2]Includes 32.1340 and 24.5800 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2023 and 06/30/2023.
[F3]Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
[F4]The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
[F5]On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F6]On September 1, 2021, the reporting person was granted 1,486 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F7]On September 2, 2020, the reporting person was granted 1,637 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F8]On September 3, 2019, the reporting person was granted 2,629 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
[F9]On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

BIO-RAD LABORATORIES, INC.

CIK 0000012208

→

Entity typeother

Related Parties

filerCIK 0001900904

Filing Metadata

Form type: 4
Filed: Sep 5, 8:00 PM ET
Accepted: Sep 6, 12:55 PM ET
Size: 31.0 KB

View on SEC.gov